212 results on '"Leppänen, Veli-Matti"'
Search Results
2. Expression of R-Spondin 1 in ApcMin/+ Mice Suppresses Growth of Intestinal Adenomas by Altering Wnt and Transforming Growth Factor Beta Signaling
3. VEGF-C protects the integrity of the bone marrow perivascular niche in mice
4. Structural basis of Tie2 activation and Tie2/Tie1 heterodimerization
5. VEGFB/VEGFR1-Induced Expansion of Adipose Vasculature Counteracts Obesity and Related Metabolic Complications
6. The TIE Receptor Family
7. High baseline Tie1 level predicts poor survival in metastatic breast cancer
8. Intranasal administration of adenoviral vaccines expressing SARS-CoV-2 spike protein improves vaccine immunity in mouse models
9. Intranasal administration of adenoviral vaccines expressing SARS-CoV-2 spike protein improves vaccine immunity in mouse models
10. Supplementary Methods and Materials from Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib
11. Table S1 from Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib
12. Data from Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib
13. Figure S1 from Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib
14. The role and regulation of integrins in cell migration and invasion
15. Comparison of vascular growth factors in the murine brain reveals placenta growth factor as prime candidate for CNS revascularization
16. Structural and mechanistic insights into VEGF receptor 3 ligand binding and activation
17. Thermodynamic and structural description of allosterically regulated VEGFR-2 dimerization
18. Lymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell-surface expression
19. Structural Determinants of Growth Factor Binding and Specificity by VEGF Receptor 2
20. Lymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell-surface expression
21. Structural determinants of vascular endothelial growth factor-D receptor binding and specificity
22. SnapShot: Angiopoietins and Their Functions
23. Effective Suppression of Vascular Network Formation by Combination of Antibodies Blocking VEGFR Ligand Binding and Receptor Dimerization
24. The Structure of the Glial Cell Line-derived Neurotrophic Factor-Coreceptor Complex: INSIGHTS INTO RET SIGNALING AND HEPARIN BINDING
25. The Schlemmʼs canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel
26. The structure of GFRα1 domain 3 reveals new insights into GDNF binding and RET activation
27. Characterization of ANGPT2 mutations associated with primary lymphedema
28. Investigation on the role of biallelic variants in VEGF‐C found in a patient affected by Milroy‐like lymphedema
29. Characterization of Symmetric Complexes of Nerve Growth Factor and the Ectodomain of the Pan-neurotrophin Receptor, p75NTR
30. The structure of the conserved neurotrophic factors MANF and CDNF explains why they are bifunctional
31. Characterization of mutations associated with primary lymphedema
32. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo
33. Abstract LB-094: Systemic RSPO1 delivery leads to regression of intestinal adenomas via activation of the TGFβ/SMAD pathway
34. Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib
35. Transcription Factor PROX1 Suppresses Notch Pathway Activation via the Nucleosome Remodeling and Deacetylase Complex in Colorectal Cancer Stem–like Cells
36. Vascular endothelial growth factor signaling in development and disease
37. Abstract 1625: Clinical biomarkers of survival in renal cell carcinoma patients treated with sorafenib
38. Abstract 1143: Prox1 and Notch mark distinct colorectal cancer stem cell populations
39. The Extreme Thermostable Pyrophosphatase fromSulfolobus acidocaldarius:Enzymatic and Comparative Biophysical Characterization
40. Pyruvate formate lyase is structurally homologous to type I ribonucleotide reductase
41. Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1
42. Loss-of-function mutations of the TIE1 receptor tyrosine kinase cause late-onset primary lymphedema.
43. VEGFR-2-specific forms of VEGF-D and VEGF-C and uses thereof
44. Functional dissection of the CCBE1 protein : A crucial requirement for the collagen repeat domain
45. Functional dissection of the CCBE1 protein: A crucial requirement for the collagen repeat domain
46. Functional Dissection of the CCBE1 Protein
47. Vascular Endothelial Growth Factor-B in Physiology and Disease
48. CCBE1 Enhances Lymphangiogenesis via A Disintegrin and Metalloprotease With Thrombospondin Motifs-3–Mediated Vascular Endothelial Growth Factor-C Activation
49. Effect of Inductor Placement on Line Current Distortion of a Frequency Converter
50. Dimensioning considerations for LC filtering of a frequency converter
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.